# Mayo Clinic Platform

> Mayo Clinic Platform is a VC fund in Rochester backing Health Care and Medical. See 16 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Rochester, United States
- Total investments: 16
- Last investment: Jul 2025
- Lead investor: 63%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/mayo-clinic-platform
- Website: https://www.mayoclinicplatform.org/

Mayo Clinic Platform is a VC fund in Rochester focused on Health Care and Medical. Mayo Clinic Platform is partnering with providers, pharmaceutical companies, medical device companies, health tech startups, and patients.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 9 | 56% |
| Medical | 6 | 38% |
| Artificial Intelligence | 4 | 25% |
| Wellness | 3 | 19% |
| Personal Health | 3 | 19% |

21 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 7 | 44% |
| Series A | 2 | 13% |
| Pre-Seed | 1 | 6% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 7 | 44% |
| India | 1 | 6% |
| Israel | 1 | 6% |
| Singapore | 1 | 6% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Respiree | They offer platforms that are able to report clinical deterioration and provide recommended interventions with post-monitoring.They work in the health care industry, just like you. We take the time to get to know you, and we always keep your best interests in mind when adding and adjusting products in our catalog. | $11.6M | Series A | Jul 23, 2025 |  |
| Naviday Health | Naviday Health is building personalized, AI-guided care pathways—starting with menopause—to help individuals confidently navigate complex health transitions. Our platform empowers daily decision-making through tailored insights, symptom tracking, and holistic support, bridging the gap between traditional care and real-world needs. We’re redefiningwhat it means to stay well every day. | $300K | Pre-Seed | Mar 01, 2025 |  |
| AccurKardia | AccurKardia provides clinical-grade, device-agnostic, API-accessible ECG analytics. | $2.7M | Seed | Jun 20, 2023 |  |
| Saigeware | Saigeware focuses on providing actionable insights into the field of health. Saigeware was founded in 2020 and was headquartered in Karnataka, India. | $200K | Seed | Mar 13, 2023 |  |
| SOAP Health | SOAP helps patients and physicians make better decisions by capturing and analyzing detailed patient data pre-visit, offering augmented intelligence at the point of care, graphically representing risk, and providing actionable insights to improve clinical decision-making. It identifies, verifies, and simplifies accurate and completepatient-reported data collection, risk assessment, documentation, and electronic delivery to physicians in a 90% completed SOAP (Subjective, Objective, Assessment, Plan) Note to improve patient care and doctor productivity, and decrease liability exposure.The company was founded in 2019 and is based in Boca Raton, Florida. | $2M | Seed | Sep 22, 2022 |  |
| SOAP Health | SOAP helps patients and physicians make better decisions by capturing and analyzing detailed patient data pre-visit, offering augmented intelligence at the point of care, graphically representing risk, and providing actionable insights to improve clinical decision-making. It identifies, verifies, and simplifies accurate and completepatient-reported data collection, risk assessment, documentation, and electronic delivery to physicians in a 90% completed SOAP (Subjective, Objective, Assessment, Plan) Note to improve patient care and doctor productivity, and decrease liability exposure.The company was founded in 2019 and is based in Boca Raton, Florida. | $2M | Seed | Sep 22, 2022 |  |
| Biotia | Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid and precise infectious disease discovery. Their software and laboratory technology enable clinicians and researchers to guide patient treatment and improve health outcomes. | $8M | Series A | Aug 23, 2022 |  |
| Biotia | Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid and precise infectious disease discovery. Their software and laboratory technology enable clinicians and researchers to guide patient treatment and improve health outcomes. | $8M | Series A | Aug 23, 2022 |  |
| Predicta Med | Predicta Med is a decision support platform for early detection and intervention selection of autoimmune diseases. Our platform gives healthcare providers an AI-powered method for shortening the diagnostic process of identifying autoimmune diseases and by that could enhance provider’s efficiency, improve treatment effectiveness and patient'scare. A process which typically takes more than four years and at least four different doctors can be shortened significantly using our platform. |  | Seed | Aug 10, 2022 |  |
| Dynocardia | Dynocardia, a biomedical device development company, committed to satisfying critical unmet needs to improve healthcare. It offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable, mobile, and easy to use, with the accuracy of intra-arterial lines. The company was founded in 2018 and headquartered in Lowell, Massachusetts. |  | Seed | Aug 10, 2022 |  |

10 of 16 investments shown.

## Co-investors
- [Ambit Health Ventures](https://shizune.co/investors/profile/ambit-health-ventures) — VC Fund, 2 deals together
- [Boutique Venture Partners](https://shizune.co/investors/profile/boutique-venture-partners) — VC Fund, 2 deals together
- [Continuum Health Ventures](https://shizune.co/investors/profile/continuum-health-ventures) — VC Fund, 2 deals together
- [Falcon Ventures](https://shizune.co/investors/profile/falcon-ventures) — VC Fund, 2 deals together
- [Hyperplane](https://shizune.co/investors/profile/hyperplane-venture-capital) — VC Fund, 2 deals together
- [Leawood Venture Capital](https://shizune.co/investors/profile/leawood-capital) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Mayo Clinic Platform invest in?

Mayo Clinic Platform invests primarily in Health Care, Medical and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 16 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Mayo Clinic Platform last invest?

The most recent investment recorded for Mayo Clinic Platform closed in Jul 2025. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co